Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 19 | 16 | 14 | 22 | 23 |
| Other Working Capital | -51 | 490 | 210 | 414 | -667 |
| Other Operating Activity | -9,225 | -4,604 | -2,656 | -2,583 | -2,102 |
| Operating Cash Flow | $-9,257 | $-4,098 | $-2,431 | $-2,147 | $-2,746 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -100 | -24 | -13 | 0 | 0 |
| Purchase Of Investment | N/A | N/A | 2,325 | 0 | -2,979 |
| Sale Of Investment | 250 | N/A | N/A | 0 | 0 |
| Other Investing Activity | 74 | 44 | 26 | 21 | 12 |
| Investing Cash Flow | $224 | $20 | $2,338 | $21 | $-2,967 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,246 | 8,855 | 2,511 | 2,031 | 4,681 |
| Other Financing Activity | 6,323 | 0 | 324 | 0 | 0 |
| Financing Cash Flow | $11,569 | $8,855 | $2,835 | $2,031 | $4,681 |
| Exchange Rate Effect | 0 | 0 | 599 | -260 | -245 |
| Beginning Cash Position | 15,408 | 10,631 | 7,946 | 8,300 | 9,195 |
| End Cash Position | 17,944 | 15,408 | 10,631 | 7,946 | 7,917 |
| Net Cash Flow | $2,536 | $4,777 | $2,741 | $-95 | $-1,032 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,257 | -4,098 | -2,431 | -2,147 | -2,746 |
| Capital Expenditure | -100 | -24 | N/A | N/A | N/A |
| Free Cash Flow | -9,357 | -4,122 | -2,431 | -2,147 | -2,746 |